(Q34301165)

1 August 2017

1 reference

title

What is cancer chemotherapy? (English)

1 reference

1 August 2017

1 reference

1

P Nygren

1 reference

1 August 2017

SBU-group. Swedish Council on Technology Assessment in Health Care

series ordinal

2

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

40

1 reference

1 August 2017

2-3

1 reference

1 August 2017

166-174

1 reference

The initial clinical trial of nitrogen mustard

1 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Current perspectives on camptothecins in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastroint

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

The cell biology of multiple drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Individual dose adaptation of anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Is there a future for cancer chemotherapy? The Michel Clavel Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

21 January 2018

Circadian cancer therapy

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Clinical trials of agents that reverse multidrug resistance. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

Apoptosis induced by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860151116204

10.1080/02841860151116204

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11441929